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Abstracts / International Journal of Surgery 23 (2015) S15eS134S118Aim: Common day case laparoscopic procedures are usually safe, with low
rates of bleeding complications. At our trust most patients undergo pre-
operative group and save (G&S) for these procedures, at a cost of £18.39
per sample excluding laboratory stafﬁng costs. Our aim was to assess if
routine G&S is indicated.
Methods: Retrospective review of all patients undergoing laparoscopic
cholecystectomy (LC), laparoscopic inguinal hernia repair (LIH) and diag-
nostic laparoscopy (DL) April 2012eMarch 2014. Patients identiﬁed using
hospital coding records. Transfusion department records were reviewed to
see which patients had undergone pre-operative G&S or cross-match, and
perioperative transfusion.
Results: 532 procedures in 2 years, 0 patients transfused for bleeding
complications. 1 patient transfused to optimise pre-existing anaemia.*
Procedure: n/G&S (%)/Crossmatch (%)/Transfused (%)
LC: 293/256 (87)/8 (3)/0
LIH: 123/67 (54)/2 (1.6)/0
DL: 116/88 (76)/6 (5)/1* (0.9)
Total G&S cost £7558.
Conclusion: The transfusion rate for bleeding complications following
laparoscopic day case surgery is 0% in our unit. G&S samples cost £7558
over 2 years. Abandoning pre-operative G&S appears to be clinically
indicated and would lead to substantial ﬁnancial savings.
0543: AUDIT OF VENOUS THROMBOEMBOLIC ASSESSMENT IN GENERAL
SURGERY
A. Pervez*, M. Velasco, A. Schizas. St Thomas' Hospital, UK
Aim: Identify patients not risk assessed for VTE prophylaxis in general
surgery and recognize clinical areas where assessment can be improved.
Re-audit VTE assessment following implementation of changes.
Methods: Cycle 1: Data collection on VTE assessments performed over a
two-week period in General Surgery using the central database, with a
focus on the type of surgical admission and grade of Doctor undertaking
the assessment. Cycle 2: Following the implementation of changes a re-
audit was carried out over another two-week period.
Results: The actual number of VTE assessments done within 24 h on the
central database was 61% (UGI) and 74% (LGI), which improved in Cycle
2e85% (UGI) and 90% (LGI). Of the total number of VTE assessments not
done - 63% (UGI) and 50% (LGI) were in day case surgery, which
improved to 20% (LGI) with minimal change for 61% (UGI) in cycle 2. The
grade of doctor for undertaking VTE assessments remained relatively
unchanged.
Conclusion: Following an awareness campaign and changes to data cap-
ture on the central database, overall number of VTE assessments per-
formed in General Surgery improved following re-audit. For Lower GI, the
number of VTE assessments not performed for day case surgery was also
signiﬁcantly improved.
0565: EFFICIENCY OF THE COMPLETION OF DIAGNOSTIC SERUM
AMYLASE FOR PATIENTS PRESENTING WITH ACUTE ABDOMINAL PAIN
T. Cheung, R. Clifford*, S. Siew, R. Gunasekera. Southport and Ormskirk
Hospital NHS Trust, UK
Aim: To evaluate the efﬁciency of the completion of serum amylase as a
diagnostic investigation for all patients admitted under the general sur-
gical team presenting with acute abdominal pain at Southport and Orm-
skirk Hospital NHS Trust.
Methods: Prospective data collection of all patients, from all referral
sources, with acute abdominal pain during a 4week period.
Results: 115 patientswere identiﬁed; 40.9%male, 59.1% female. Age range
19e91years.102 patients (88.7%) had serum amylase completed; 96.1% on
admission, 3.9%within the ﬁrst 48 h 13 patients (11.3%) had no amylase; 5
(38.5%) presenting with upper abdominal pain; 2 (15.4%) with no formal
diagnosis after Consultant review at 48 h 43 (37.4%) patients presented
with localised epigastric pain; 9 (7.8%) of whom were managed as serum
amylase rise conﬁrmed acute pancreatitis.Conclusion: Acute pancreatitis is estimated to account for 3% of all hos-
pital admissions within the UK; with a rising incidence. Although mor-
tality rates have improved due to early diagnosis and clear guidelines, up
to 25% of patients develop severe or life-threatening complications
requiring higher-level care. Serum amylase level should be completed for
all patients presenting with acute abdominal pain to ensure accurate and
timely diagnosis and appropriate patient care.
0703: FEASIBILITY OF DAY CASE LAPAROSCOPIC CHOLECYSTECTOMY IN
A DISTRICT GENERAL HOSPITAL
K. Smith*, S. Rashid. Wishaw General Hospital, UK
Aim: A prospective study was carried out to assess the feasibility of per-
forming day case surgery in a district general hospital.
Methods: All patients admitted for day case laparoscopic cholecystectomy
over a twelve-month period were included in the study. Selection criteria
for a day case procedure included having an ASA status of I or II and having
a responsible carer at home. Patients were discharged 4e6 h after surgery
with a standard analgesia pack. Patients were then telephoned within 48 h
of discharge.
Results: 78 patients underwent day case lap chole over a 9month period. 6
patients (7.7%) were admitted to the ward. Of those discharged only 9
(12.5%) required further advice, 6 (8.3%) felt the analgesia was ineffective
and 13 (18.1%) felt their analgesia was ineffective. Overall 79.2% of patients
were satisﬁed with the service.
Conclusion: This study has demonstrated a reasonable rate of overnight
stay (7.7%) and a high degree of patient satisfaction (79.2%), showing
that it is feasible to perform this procedure as a day case in selected
patients.
0712: CAN WE PREDICT THE RESPONSE TO NEOADJUVANT THERAPY IN
UPPER GI CANCER? A SYSTEMATIC REVIEW OF CANDIDATE
BIOMARKERS
D. Bunting. Derriford Hospital, UK
Aim: Neoadjuvant therapies are used in the treatment of oesophago-
gastric cancer to improve on poor outcomes and use has increased since
evidence has suggested modest overall beneﬁts. Only a minority of pa-
tients respond to therapy and typical 5-year-survival is still poor at
23e47%. Patients not responding risk the toxic effects of chemotherapy/
chemoradiotherapy which may lead to abandoning curative treatments
and a delay to surgery. There is a pressing need to ﬁnd ways of predicting
response to neoadjuvant therapy. Biomarkers offer the most potential and
can be divided into two groups depending on whether they are sourced
from tumour tissue or blood serum/plasma.
Methods: A systematic review of the Medline, CINAHL and EMBASE da-
tabases was performed using the NHS library and PubMed. Reference lists
were cross-checked and the PubMed related articles feature was used to
identify further relevant articles. A consort diagram details the search
process.
Results: 52 studies were identiﬁed including a total of 6123 patients and
48 separate biomarkers. Markers were grouped according tomechanism of
action and studies are summarised in tissue marker and plasma/serum
marker tables.
Conclusion: There are many potentially useful markers. The solution will
be provided by a panel of candidate markers but they require validation in
prospective studies.
0789: MAKING DIFFICULT, EASIER: STANDARDISATION OF TECHNIQUE
OF LAPAROSCOPIC CHOLECYSTECTOMY IN THE MORBIDLY OBESE
PATIENT: A TRAINEE'S AND SURGEON'S EXPERIENCE
A. Mastan*, N. Krishnamohan, Y.L. Goh, R.S. Date. Royal Preston Hospital,
UK
Aim: Laparoscopic cholecystectomy (LC) in the morbidly obese (MO) pa-
tient is increasingly encountered by surgical trainees. In MO patients, this
operation is technically demanding. Further, conversion to an open pro-
cedure increases morbidity. We describe a systematic approach to
